Evidence map›Paper›PMID 20027183›Full record

ArticleNature2010

Human host factors required for influenza virus replication.

Renate König, Silke Stertz, Yingyao Zhou, Atsushi Inoue, H-Heinrich Hoffmann, Suchita Bhattacharyya, Judith G Alamares, Donna M Tscherne, Mila B Ortigoza, Yuhong Liang and 16 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 522 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
522citing papers in PubMed, 2 pooled it
38.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

522 citing papers in PubMed, 2 syntheses or guidelines pooled it, 820 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The ribosomal landscape in influenza A virus infection: from molecular mechanisms to clinical relevance.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  12. Article
  13. Advancing influenza virus treatment:Materials today. Bio · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Shared host genetic landscape of respiratory viral infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  20. Article

462 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 2 countries.

Renate KönigInfectious and Inflammatory Disease Center, Burnham Institute for Medical Research.
Silke Stertz
Yingyao Zhou
Atsushi Inoue
H-Heinrich Hoffmann
Suchita Bhattacharyya
Judith G Alamares
Donna M Tscherne
Mila B Ortigoza
Yuhong Liang
Qinshan Gao
Shane E Andrews
Sourav Bandyopadhyay
Paul De Jesus
Buu P Tu
Lars Pache
Crystal Shih
Anthony Orth
Ghislain Bonamy
Loren Miraglia
Trey Ideker
Adolfo García-Sastre
John A T Young
Peter Palese
Megan L Shaw
Sumit K Chanda
Czech Academy of Sciences, Institute of Microbiology · CZSanford Burnham Prebys Medical Discovery Institute · USGenomics Institute of the Novartis Research Foundation · USSalk Institute for Biological Studies · USUniversity of California, San Diego · USOffice of Infectious Diseases · US

Funding

Treatments for Nipah Virus InfectionU54AI057159 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WHELAN, SEAN PJ · 2003 to 2013
$113.7M
Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
MOUNT SINAI MEDICAL SCIENTIST TRAINING PROGRAMT32GM007280 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BARON, MARGARET H · 1985 to 2021
$22.8M
Viral and Host cDNA Libraries from 1918 Influenza CasesP01AI058113 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GARCIA-SASTRE, ADOLFO · 2004 to 2010
$20.3M
TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
NOVEL CELLULAR AND VIRAL TARGETS FOR ANTI-INFLUENZA VIRUS DRUGSU01AI074539 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PALESE, PETER · 2007 to 2011
$7.4M
Advanced Microscopy Shared Resource FacilityR24CA095823 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FRIEDRICH, VICTOR LOUIS · 2002 to 2006
$1.3M
INHIBITION OF INFLUENZA VIRUS NS1 FUNCTION BY SMALL MOLECULESR21AI083673 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SHAW, MEGAN LOUISE · 2009 to 2010
$453k
Novel role of 1918 influenza virus neuraminidase in hemagglutnin activationF32AI081428 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TSCHERNE, DONNA · 2009 to 2010
$57k
CONFOCAL MICROSCOPE FACILITYS10RR009145 · NCRR · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · PI MASUR, SANDRA K · 1994 to 1994
–
NCI NIH HHS 5R24 CA095823-04NCI NIH HHS R24 CA095823NCRR NIH HHS 1 S10 RR0 9145-01NIAID NIH HHS 1F32AI081428NIAID NIH HHS 1 P01 AI058113NIAID NIH HHS 1R21AI083673NIAID NIH HHS 1 T32 AI07647NIAID NIH HHS F32 AI081428NIAID NIH HHS HHSN266200700010CNIAID NIH HHS HHSN272200900032CNIAID NIH HHS P01 AI058113NIAID NIH HHS R21 AI083673NIAID NIH HHS T32 AI007647NIAID NIH HHS U01 AI074539NIAID NIH HHS U01 AI1074539NIAID NIH HHS U54 AI057158NIAID NIH HHS U54 AI057159NIGMS NIH HHS T32 GM007280
6 · The paper itself

Abstract

Influenza A virus is an RNA virus that encodes up to 11 proteins and this small coding capacity demands that the virus use the host cellular machinery for many aspects of its life cycle. Knowledge of these host cell requirements not only informs us of the molecular pathways exploited by the virus but also provides further targets that could be pursued for antiviral drug development. Here we use an integrative systems approach, based on genome-wide RNA interference screening, to identify 295 cellular cofactors required for early-stage influenza virus replication. Within this group, those involved in kinase-regulated signalling, ubiquitination and phosphatase activity are the most highly enriched, and 181 factors assemble into a highly significant host-pathogen interaction network. Moreover, 219 of the 295 factors were confirmed to be required for efficient wild-type influenza virus growth, and further analysis of a subset of genes showed 23 factors necessary for viral entry, including members of the vacuolar ATPase (vATPase) and COPI-protein families, fibroblast growth factor receptor (FGFR) proteins, and glycogen synthase kinase 3 (GSK3)-beta. Furthermore, 10 proteins were confirmed to be involved in post-entry steps of influenza virus replication. These include nuclear import components, proteases, and the calcium/calmodulin-dependent protein kinase (CaM kinase) IIbeta (CAMK2B). Notably, growth of swine-origin H1N1 influenza virus is also dependent on the identified host factors, and we show that small molecule inhibitors of several factors, including vATPase and CAMK2B, antagonize influenza virus replication.

Indexed as

AnimalsBiological FactorsCell LineChlorocebus aethiopsGene LibraryGenome, HumanHost-Pathogen InteractionsHumansInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza, HumanRNA InterferenceVero CellsVirus InternalizationVirus ReplicationBiological Factors

Identifiers

PMID20027183
PMCPMC2862546
OpenAlexW2070924692

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.